- Home
- GVA vs ACLX Comparison
GVA vs ACLX Comparison
Compare GVA & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GVA
- ACLX
- Stock Information
- Founded
- GVA 1922
- ACLX 2015
- Country
- GVA United States
- ACLX United States
- Employees
- GVA N/A
- ACLX N/A
- Industry
- GVA Military/Government/Technical
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- GVA Industrials
- ACLX Health Care
- Exchange
- GVA Nasdaq
- ACLX Nasdaq
- Market Cap
- GVA 4.0B
- ACLX 3.7B
- IPO Year
- GVA 1990
- ACLX 2022
- Fundamental
- Price
- GVA $89.01
- ACLX $63.00
- Analyst Decision
- GVA Strong Sell
- ACLX Strong Buy
- Analyst Count
- GVA 1
- ACLX 14
- Target Price
- GVA $76.00
- ACLX $111.42
- AVG Volume (30 Days)
- GVA 549.5K
- ACLX 631.2K
- Earning Date
- GVA 07-31-2025
- ACLX 08-07-2025
- Dividend Yield
- GVA 0.58%
- ACLX N/A
- EPS Growth
- GVA 218.05
- ACLX N/A
- EPS
- GVA 2.58
- ACLX N/A
- Revenue
- GVA $4,034,846,000.00
- ACLX $76,809,000.00
- Revenue This Year
- GVA $7.95
- ACLX N/A
- Revenue Next Year
- GVA $6.03
- ACLX $112.68
- P/E Ratio
- GVA $34.51
- ACLX N/A
- Revenue Growth
- GVA 11.42
- ACLX N/A
- 52 Week Low
- GVA $58.23
- ACLX $47.86
- 52 Week High
- GVA $105.20
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- GVA 55.50
- ACLX 47.45
- Support Level
- GVA $88.17
- ACLX $64.77
- Resistance Level
- GVA $90.20
- ACLX $66.73
- Average True Range (ATR)
- GVA 1.66
- ACLX 2.89
- MACD
- GVA -0.49
- ACLX -0.35
- Stochastic Oscillator
- GVA 27.56
- ACLX 25.18
About GVA Granite Construction Incorporated
Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.